Drugs · acquisition-cost intelligence
codeine sulfate
· ingredient codeineOpium alkaloids and derivatives· CODEINE SULFATE 15 mg/1; CODEINE SULFATE 30 mg/1; CODEINE SULFATE 60 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.66534
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-02-192026-05-20
Same-ingredient options by acquisition cost
Other codeine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Codeine-Guaifenesin | $0.04287 | −$0.62250 |
| Promethazine Hydrochloride and Codeine Phosphate | $0.05769 | −$0.60770 |
Medicare Part D coverage · CY2026
On 50 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 84% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.